Core Viewpoint - The company *ST Zhengping is facing significant risks related to asset impairment, potential negative net assets, and unresolved non-standard audit opinions, which may lead to delisting if not addressed promptly [1][5]. Group 1: Asset Impairment Risks - As of the end of Q3 2025, *ST Zhengping reported accounts receivable, contract assets, and other receivables totaling over 3.6 billion yuan, while the net assets were only 280 million yuan, resulting in a high debt ratio of 92.49% [2]. - The company has not adequately accounted for impairment on long-term equity investments totaling 4.27 billion yuan and other equity instruments valued at 1.29 billion yuan, raising concerns about the sufficiency of impairment provisions [2]. Group 2: Debt Claim Reporting Issues - The company is undergoing pre-restructuring, with the debt claim reporting deadline set for January 25, 2026, but significant flaws in the reporting process may hinder the elimination of non-standard audit opinions [3]. - The debt claim reporting only includes the parent company and 13 subsidiaries, excluding major subsidiaries with substantial debts, which raises doubts about the accuracy and completeness of the claims [3]. Group 3: Revenue and Cost Measurement Concerns - The accuracy of revenue recognition and cost measurement is under scrutiny, as previous audits indicated discrepancies in project settlements and internal control deficiencies [4]. - The company anticipates revenue between 950 million and 1.35 billion yuan for 2025, but the lack of effective internal controls raises questions about the reliability of this revenue recognition [4]. Group 4: Regulatory Attention and Future Implications - The receipt of the regulatory work letter from the Shanghai Stock Exchange indicates heightened scrutiny of the company's risk issues, which must be resolved to maintain its listing status [5]. - If the 2025 financial report continues to receive non-standard opinions or if net assets remain negative, the company may face delisting under relevant regulations [5].

Core Viewpoint - *ST Zhengping has announced an expected positive net asset value by the end of 2025, but has received further inquiries from regulators regarding its financial stability and potential delisting risks [2][6]. Financial Performance and Projections - The company forecasts a net asset value between 250 million to 370 million yuan by the end of 2025, despite anticipated losses in net profit [2][6]. - The expected operating revenue for 2025 is projected to exceed 300 million yuan [6]. Regulatory Inquiries - The Shanghai Stock Exchange has issued a regulatory letter requiring *ST Zhengping to verify and supplement details related to its 2025 performance forecast, focusing on three main issues: impairment of receivables, validity of debt claims, and revenue recognition [5][9]. - The company has been asked to clarify the expected recovery time for receivables totaling 3.65 billion yuan, which significantly exceeds its projected net assets [9]. Audit Concerns - The annual auditor has expressed uncertainty regarding the company's ability to achieve a positive net asset value, highlighting the risk of delisting due to negative net assets [6][10]. - Issues related to revenue recognition and cost measurement have led to non-standard audit opinions for 2024, which may affect the 2025 financial report [10]. Internal and External Challenges - The actual control of *ST Zhengping is under pressure, with all shares held by its controllers frozen due to lawsuits related to unpaid bank loans totaling 1.03 billion yuan and 12 million yuan [11][14]. - The company's stock has experienced significant volatility, with a cumulative increase of 52.69% followed by a drop of 24.96% within a short period [14][18].

*ST生物公告称，2024年度公司利润总额、净利润、扣非后净利润均为负值，扣除后营业收入低于3亿 元，股票于2025年4月30日起被实施退市风险警示。若2025年度出现《深圳证券交易所股票上市规则 （2025年修订）》第9.3.12条规定的情形，如经审计的利润总额等三者孰低为负值且扣除后营收低于3亿 元等，公司股票将被终止上市。公司曾于2026年1月23日披露相关风险提示公告。 ...

Core Viewpoint - *ST Zhengping is facing significant financial challenges, with projected losses for 2025 and potential risks of delisting due to negative net assets [1][2][4] Financial Projections - The company anticipates a total profit loss for 2025 between -450 million yuan and -360 million yuan, with a net profit attributable to shareholders expected to be between -430 million yuan and -340 million yuan [1] - The projected operating revenue for 2025 is estimated to be between 950 million yuan and 1.35 billion yuan, with adjusted revenue (excluding non-core business income) expected to be between 940 million yuan and 1.34 billion yuan [1] Net Asset Concerns - *ST Zhengping estimates its net assets at the end of 2025 to be between 250 million yuan and 370 million yuan, but this is subject to change pending the completion of the annual audit [2] - There is a significant risk that the net assets could be negative, which would trigger delisting regulations under the Shanghai Stock Exchange rules [2][4] Audit and Compliance Issues - The auditing firm, Zhongrui Cheng, has indicated that they cannot confirm the positive net asset projection due to ongoing audit procedures, which raises concerns about the company's financial stability [3] - The company has not yet resolved the non-standard audit opinion from 2024, which could affect the 2025 financial report [4] Historical Financial Performance - In 2024, *ST Zhengping reported an operating revenue of 1.36 billion yuan, with a total profit loss of -546.71 million yuan and a net profit attributable to shareholders of -483.93 million yuan [3] - The company has faced challenges in maintaining positive audit opinions, which could lead to further financial scrutiny and potential delisting [4] Fundraising History - Since its listing in 2016, *ST Zhengping has raised a total of 941 million yuan through two fundraising rounds [5] - The company raised 440 million yuan through a non-public offering in 2021, with net proceeds of 435 million yuan after deducting issuance costs [5]

2月3日，因公司董事会秘书（以下简称"董秘"）一职长期空缺，*ST岩石（原岩石股份）、鹏欣资 源先后收到上交所开出的警示函。 董秘长期缺位这一违规事项，仅是*ST岩石公司治理失效的冰山一角。*ST岩石全称为上海贵酒股 份有限公司，成立于1989年，主营白酒行业。近年来，*ST岩石可谓多重风险高悬：各类诉讼缠身、经 营基本停滞、业绩持续承压、股份遭冻结等，公司实际控制人韩啸更是与2023年底的海银财富管理有限 公司（以下简称"海银财富"）爆雷存在千丝万缕的关系。 2024年9月11日，*ST岩石的风险迎来集中爆发。据公司发布的公告，实际控制人韩啸因海银财富 非法集资案，已被作为关联嫌疑人采取刑事强制措施。据悉，海银财富实控人韩宏伟是韩啸的父亲，韩 啸本人也曾是海银财富控股股东海银控股的股东之一。 同日披露的另一份公告显示，此事件已直接波及上市公司股权：公司控股股东上海贵酒企业发展有 限公司（以下简称"贵酒发展"）及其一致行动人所持有的全部股份已被司法冻结，占公司总股本的 64.80%。而韩啸正是通过绝对控股贵酒发展及其一致行动人（如五牛基金等）实现对上市公司的绝对 控制。目前，韩啸所涉案件已按照集资诈骗案被公安 ...

将视野放宽，2026年元旦之后，涉及审计机构辞任或改聘的上市公司数量已达到8家。这些公司普遍呈 现业绩亏损、半数已被"披星戴帽"的特点，其密集更换审计机构的举动，在年关时点显得格外突兀。 在全面从严监管的背景下，审计机构在元旦后的辞任或改聘行为，通常并非偶然。现象背后，折射出审 计机构对上市公司审计的审慎态度：或是因业务超载而主动舍弃质地相对不佳的客户，或是因团队变动 而无力承接，更关键的是，有的会计所在审计过程中为规避难以调和的风险与潜在的监管处罚而选 择"辞任自保"。 这一系列举动，无疑为相关上市公司的年报披露之路增添了更大的不确定性，并为其本就严峻的退市风 险敲响了警钟。 年报披露"冲刺期"遇阻：两家*ST公司审计机构"悬空" 年报披露进入最后三个月的倒计时，这本应是审计机构进场、全面展开审核的关键阶段。然而，市场却 出现了令人关注的现象：个别上市公司，正面临"审计师难觅"的窘境。 截至2月2日，*ST海华与*ST赛隆两家公司甚至在审计机构仓促辞任后，至今未能确定新的年审会计师 事务所，退市风险骤然加剧。 4月30日是上市公司披露年报的最后截止日。倒计时3个月，年报审核通常已进入关键阶段，审计机构 （会 ...

Core Viewpoint - The company *ST Aiai's stock has experienced a significant abnormal fluctuation, with a cumulative decline of 12% over three consecutive trading days, prompting an announcement regarding its operational status and potential risks [1] Group 1: Stock Performance and Trading Status - The stock price of *ST Aiai has deviated significantly, with a cumulative drop of 12% over the trading days of February 2, 3, and 4, 2026, indicating abnormal trading conditions [1] - The company has been placed under delisting risk warning, and if the 2025 annual report does not meet the criteria for lifting this warning or is not submitted within the required timeframe, the stock may face termination of listing [1] Group 2: Operational Status and Financial Outlook - The company has confirmed that its production and operational activities are normal, with no significant changes in the internal or external business environment [1] - There are no undisclosed major events that could impact the stock price, such as major asset restructuring, share issuance, acquisitions, or significant business collaborations [1] - The 2025 annual performance forecast indicates uncertainty regarding whether the revenue, after excluding unrelated business income, will exceed 300 million yuan, with potential risks related to the revenue from the new energy battery components business [1]

ST华鹏公告称，公司股票于2026年2月3 - 4日连续两个交易日涨停，价格波动大，涨幅高于同期上证指 数。2026年1月24日业绩预告显示，预计2025年净利润为-2.63亿元至 - 1.94亿元，期末净资产为-2.08亿 元到 - 1.39亿元，业绩亏损且净资产为负。经测算，公司股票在2025年年度报告披露后可能被上交所实 施退市风险警示。截至公告日，公司主营、经营情况无重大变化，也无应披露未披露重大事项。 ...

Group 1 - Both *ST Yanshi and Pengxin Resources have long-term violations regarding the duties of the board secretary being performed by others, with *ST Yanshi's duties being carried out by the vice chairman since September 12, 2024, and Pengxin Resources' duties by the chairman since January 21, 2022 [3][4] - The Shanghai Stock Exchange has issued regulatory warnings to both companies, requiring them to rectify the violations and submit a rectification report within one month, along with initiating the appointment process for a qualified board secretary [3][4] - The role of the board secretary is crucial for corporate governance, ensuring effective decision-making and protecting shareholder rights, as well as fulfilling legal disclosure obligations [3] Group 2 - Pengxin Resources has a stable operational foundation and is expected to achieve a net profit of 210 million to 290 million yuan in 2025, marking a turnaround from previous losses [4] - In contrast, *ST Yanshi is facing multiple risks, including ongoing lawsuits, stagnant operations, and a significant decline in performance, with its actual controller linked to a financial scandal [4][5] - As of September 11, 2024, *ST Yanshi's actual controller has been implicated in a criminal case related to illegal fundraising, leading to the judicial freeze of 64.80% of the company's shares [5] - The company is at risk of being delisted due to projected negative net profits and revenues below 300 million yuan for the fiscal year 2024 [5][6] - *ST Yanshi is involved in 552 legal cases, with a recent loss in a contract dispute adding to its financial pressures, leaving it with only 1.3425 million yuan in cash against short-term borrowings of 25.2 million yuan [6]

Core Viewpoint - ST Lingnan and ST Huaxi are facing delisting risks due to performance indicators hitting red lines, leading to the imposition of "*ST" status [1][3] Group 1: Financial Performance and Risks - ST Lingnan has triggered two delisting red lines as per Shenzhen Stock Exchange rules: negative profit totals and net assets, with a total loss exceeding 3.6 billion yuan over three years [3] - ST Huaxi is expected to have negative net assets by the end of 2025, which also triggers delisting risk warnings [3] - Both companies have previously faced other risk warnings due to ongoing issues [3] Group 2: Regulatory and Compliance Issues - ST Lingnan has been under investigation for information disclosure violations since September 2025, with prior warnings about inflated revenue and inadequate provisions [5] - ST Huaxi faced scrutiny in April 2025 for a significant revision of its earnings forecast, changing from profit to loss [5] Group 3: Investor Actions and Legal Recourse - Investors affected by the companies' performance can pursue legal claims, with specific timeframes outlined for ST Lingnan and ST Huaxi [7] - Legal actions are being prepared by law firms on behalf of investors who suffered losses during specified periods [7]